Maxcyte (MXCT) Total Current Liabilities (2020 - 2026)
Maxcyte (MXCT) posted quarterly Total Current Liabilities of $10.2 million for Q1 2026, down 19.8% year-over-year from $12.7 million in Q1 2025, and down 28.42% quarter-over-quarter from $14.3 million in Q4 2025.
Maxcyte (MXCT) Total Current Liabilities (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Total Current Liabilities for 7 consecutive years, with $10.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 19.8% year-over-year to $10.2 million; the TTM figure through Mar 2026 stood at $10.2 million (down 19.8% YoY), while the FY2025 annual figure was $14.3 million, down 9.56% from the prior year.
- Total Current Liabilities eased to $10.2 million in Q1 2026 per MXCT's latest filing, from $14.3 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $18.1 million in Q2 2022 and bottomed at $10.2 million in Q1 2026.
- Historically, Total Current Liabilities has averaged $15.0 million across 5 years, with a median of $15.5 million in 2022.
- Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 44.46% — and 2023, when it fell 27.08%.
- Maxcyte's Total Current Liabilities stood at $15.4 million in 2022, then gained by 15.74% to $17.9 million in 2023, then fell by 11.65% to $15.8 million in 2024, then retreated by 9.56% to $14.3 million in 2025, then fell by 28.42% to $10.2 million in 2026.
- Business Quant data shows MXCT's Total Current Liabilities at $10.2 million in Q1 2026, $14.3 million in Q4 2025, and $16.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.34 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 127.40 Bn | 123.93 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 73.24 Bn | 72.71 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.39 Bn | 32.44 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.34 Bn | 23.02 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Maxcyte | 147.42 Mn | 147.42 Mn | 5.60 Mn | 9.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.90 Mn |
| Mar 31, 2026 | 10.21 Mn |
| Dec 31, 2025 | 14.27 Mn |
| Sep 30, 2025 | 16.10 Mn |
| Jun 30, 2025 | 11.56 Mn |
| Mar 31, 2025 | 12.73 Mn |
| Dec 31, 2024 | 15.78 Mn |
| Sep 30, 2024 | 17.62 Mn |
| Jun 30, 2024 | 12.28 Mn |
| Mar 31, 2024 | 13.48 Mn |
| Dec 31, 2023 | 17.86 Mn |
| Sep 30, 2023 | 16.65 Mn |
| Jun 30, 2023 | 13.20 Mn |
| Mar 31, 2023 | 16.64 Mn |
| Dec 31, 2022 | 15.43 Mn |
| Sep 30, 2022 | 16.76 Mn |
| Jun 30, 2022 | 18.11 Mn |
| Mar 31, 2022 | 15.55 Mn |
| Dec 31, 2021 | 15.62 Mn |
| Sep 30, 2021 | 12.58 Mn |